Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zahlten

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 5, 1999
[Clinical research on human subjects. (2) Preclinical]R Labs, C Staehr, R Zahlten
Journal of Cardiovascular Pharmacology|January 1, 1989
An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertensionB Bauer, H Lorenz, R Zahlten
Deutsche Medizinische Wochenschrift (1946)|June 17, 1999
[Clinical research (3). Therapeutic studies]R Labs, C Staehr, R Zahlten
Deutsche Medizinische Wochenschrift (1946)|May 26, 1999
[Clinical research on human beings (1)]R Labs, C Staehr, R Zahlten
International Journal of Clinical Pharmacology and Therapeutics|October 26, 2005
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administrationM Meyer, B Jilma, R Zahlten, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1970
Utilization of ketone bodies by adipose tissue and its regulation by carbohydrate metabolismH D Söling, R Zahlten, W V Reimold, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|June 5, 1999
[Clinical research on human subjects. (2) Preclinical]R Labs, C Staehr, R Zahlten
Journal of Cardiovascular Pharmacology|January 1, 1989
An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertensionB Bauer, H Lorenz, R Zahlten
Deutsche Medizinische Wochenschrift (1946)|June 17, 1999
[Clinical research (3). Therapeutic studies]R Labs, C Staehr, R Zahlten
Deutsche Medizinische Wochenschrift (1946)|May 26, 1999
[Clinical research on human beings (1)]R Labs, C Staehr, R Zahlten
International Journal of Clinical Pharmacology and Therapeutics|October 26, 2005
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administrationM Meyer, B Jilma, R Zahlten, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1970
Utilization of ketone bodies by adipose tissue and its regulation by carbohydrate metabolismH D Söling, R Zahlten, W V Reimold, et al.
Pageof 1